Orbimed Advisors LLC Xenon Pharmaceuticals Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 911,420 shares of XENE stock, worth $34.8 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
911,420
Previous 862,362 5.69%
Holding current value
$34.8 Million
Previous $33.6 Million 6.67%
% of portfolio
0.85%
Previous 0.81%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$36.12 - $43.96 $1.77 Million - $2.16 Million
49,058 Added 5.69%
911,420 $35.9 Million
Q2 2024

Aug 14, 2024
BUY
$36.25 - $43.75 $11.3 Million - $13.7 Million
312,362 Added 56.79%
862,362 $33.6 Million
Q4 2023

Feb 14, 2024
SELL
$28.7 - $46.46 $11.7 Million - $19 Million
-408,793 Reduced 42.64%
550,000 $25.3 Million
Q3 2023

Nov 14, 2023
SELL
$34.16 - $39.73 $4.69 Million - $5.45 Million
-137,207 Reduced 12.52%
958,793 $32.8 Million
Q2 2023

Aug 14, 2023
SELL
$34.84 - $43.54 $1.85 Million - $2.31 Million
-53,100 Reduced 4.62%
1,096,000 $42.2 Million
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $390,108 - $465,274
11,800 Added 1.04%
1,149,100 $45.3 Million
Q3 2022

Nov 14, 2022
SELL
$30.79 - $39.82 $5.91 Million - $7.64 Million
-191,900 Reduced 14.44%
1,137,300 $41.1 Million
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $16.4 Million - $22.6 Million
643,200 Added 93.76%
1,329,200 $40.4 Million
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $1.38 Million - $1.82 Million
55,000 Added 8.72%
686,000 $21 Million
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $2.4 Million - $5.45 Million
154,000 Added 32.29%
631,000 $19.7 Million
Q3 2021

Nov 15, 2021
SELL
$14.86 - $19.45 $12.7 Million - $16.7 Million
-857,217 Reduced 64.25%
477,000 $7.29 Million
Q2 2021

Aug 16, 2021
SELL
$16.81 - $20.0 $19.6 Million - $23.3 Million
-1,163,700 Reduced 46.59%
1,334,217 $24.8 Million
Q2 2020

Aug 14, 2020
BUY
$10.21 - $14.9 $8.53 Million - $12.4 Million
835,105 Added 50.22%
2,497,917 $31.3 Million
Q1 2020

May 15, 2020
BUY
$8.08 - $17.57 $8.31 Million - $18.1 Million
1,028,000 Added 161.94%
1,662,812 $18.9 Million
Q3 2017

Nov 14, 2017
BUY
$2.45 - $3.25 $1.56 Million - $2.06 Million
634,812
634,812 $1.87 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.37B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email